Fresh analysis suggests that people who come off new slimming jabs like semaglutide or tirzepatide can put back on reduced body mass far faster than those who halt conventional diet and exercise regimens.
Published data in a leading health publication shows that while obese people can lose substantial amounts of their total mass while undergoing treatment, the weight returns at an average rate of nearly a kilo each month once they quit.
"Individuals purchasing these medications must be informed of the risk of fast rebound weight gain when the medication concludes," cautioned researcher Dr. Susan Jebb.
This pace of recovery suggests a reversion to starting mass within about a year and a half.
Analyzing Therapies
The study, which reviewed dozens of studies involving over 9,000 of patients, compared the outcomes of the injectable medications with conventional dieting.
The team point out that people who lose weight through dieting generally have a slower weight regain—around 0.1 kg a month—after stopping.
Understanding the Quick Regain
Doctors propose the way of the drugs explains the accelerated rebound.
These medications imitate a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Long-term administration of the hormone levels several times higher than normal may cause the system to generate a reduced amount of its own natural hormone, and could reduce responsiveness to its actions," said Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this GLP-1 'fix' means appetite is uncontrolled, making overeating far more likely."
An Ongoing Condition?
The NHS recommend the jabs for individuals with weight-linked health risks, accompanied by recommended diet and exercise modifications.
A number of clinicians say that, due to the significant potential of relapse, the treatment might need to be long-term.
This perspective is supported by pharmaceutical companies, who note that the results "emphasize the long-term character of excess weight," similar to managing conditions like diabetes.
User Experiences
Users who have stopped the jabs describe a powerful resurgence of cravings.
"It was like something activating and you become starving," described an individual.
The struggle is worsened if patients have not adopted permanent lifestyle or habit changes during therapy.
Growing Interest
Figures indicate that a significant number of adults in the UK have tried weight-loss jabs in the past year, with desire being substantial.
- Adoption is greater among women than males.
- The 40s and 50s age group shows the highest level of interest.
- Many access the medications through private prescriptions rather than the NHS.
In conclusion, researchers emphasize that while the jabs are powerful agents for weight loss, they are not a standalone fix and lasting health benefits relies on combined behavioural management.
